The following audio is from a conference call that will begin on January 21, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.If you would like to view a transcript of this call, please click here.
J&J (JNJ +0.85%) Q4 net profit $3.52B vs $2.57B a year earlier.
Domestic sales +7.4%, international sales +2.4%
2013 results were "led by the outstanding performance in our pharmaceutical business, the strength of key brands in our U.S. OTC and other consumer businesses, and continued progress in integrating Synthes into our Medical Devices and Diagnostics business," says J&J CEO Alex Gorsky.
J&J expects 2014 EPS of $5.75-5.85 vs consensus of $5.85. (PR)